Akebia Therapeutics, Inc. (AKBA) NASDAQ
0.94
-0.0836(-8.20%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.94
-0.0836(-8.20%)
Currency In USD
| Market Cap | 414.02M |
| Enterprise Value | 445.48M |
| P/E Ratio | -12.19 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 1.08 |
| Price/Book Ratio | 9.13 |
| Enterprise/Revenue | 0.43 |
| Enterprise/EBITDA | 31.95 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.09 |
| Operating Margin | 0.02 |
| Return On Assets | -0.06 |
| Return On Equity | -0.63 |
| Revenue | 236.2M |
| Revenue/Share | 0.87 |
| Gross Profit | 196.73M |
| EBITDA | 21.73M |
| Net Income | -5.35M |
| Diluted EPS | -0.02 |
| Total Cash | 162.64M |
| Total Cash/Share | 0.61 |
| Total Debt | 12.5M |
| Total Debt/Equity | 0.46 |
| Current Ratio | 1.4 |
| Book Value Per Share | 0.1 |
| 52-Week Change | -71.19 |
| 52-Week High | 4.08 |
| 52-Week Low | 0.88 |
| Moving Average 50 Days | 1.29 |
| Moving Average 200 Days | 1.84 |
| Average Volume | 3.56M |
| Shares Outstanding | 268.26M |
| % Held by Institutions | 39.55 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |